Publication | Closed Access
Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy
37
Citations
29
References
2021
Year
OncologyMedicinePathologyPulmonary PharmacologyBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyLung CancerCancer ResearchLung Adenocarcinoma Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1